Clinical interest in the use of psychedelic drugs for the treatment of psychiatric disorders has recently exploded, with researchers testing the effects of compounds like LSD and psilocybin on patient populations that are resistant to traditional pharmacotherapies.1-4 The profound alterations in consciousness, sensory perception, and emotional state elicited by psychedelics depends on the ability…


Previous articlePT375 – Microdosing & Citizen Science: Introducing the World’s First Take-Home EEG Microdosing Study
Next articleClearmind Announces Initiation of CMND-100 Manufacturing Program to Address its Upcoming Clinical Trial